ACR Convergence 2023 Highlights: Magnetic Resonance Imaging Reflects Disease Activity in the Giant Cell Arteritis Treatment with Ultra-short Glucocorticoids and Tocilizumab Trial (The GUSTO Trial)

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ACR Convergence 2023 Highlights: Magnetic Resonance Imaging Reflects Disease Activity in the Giant Cell Arteritis Treatment with Ultra-short Glucocorticoids and Tocilizumab Trial (The GUSTO Trial)

By Highlights from ACR Convergence 2023 FEATURING Lisa Christ

0 views

December 1, 2023

The above content is not sponsored by, nor part of, the American College of Rheumatology. ...
read more ↘

View American College of Rheumatology educational opportunities here https://rheumatology.org/events-programs
↖ read less

Comments 0

An Efficacy and Safety Review for Patients With Severe Eosinophilic …

Feat. Y. Goldman

Identifying Eosinophilic Granulomatosis With Polyangiitis and Hypere…

Feat. M. O'Connor

Management of Raynaud’s Phenomenon